-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$778.10-1.05% Downside
Recent Analyst Forecasts and Stock Ratings
Eli Lilly and Company Frequently Asked Questions
-
What analysts cover Eli Lilly and Company?
Eli Lilly and Company has been rated by research analysts at BMO Capital, Leerink Partners, Citigroup, Morgan Stanley, Berenberg Bank, Deutsche Bank in the past 90 days.